glucose, (beta-d)-isomer has been researched along with Atherosclerosis in 82 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (9.76) | 29.6817 |
| 2010's | 43 (52.44) | 24.3611 |
| 2020's | 31 (37.80) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; He, C; He, F; Li, X; Liu, D | 1 |
| Chan, ZW; Chui, LG; Feingold, KR; Grunfeld, C; Kazemi, MR; Londos, C; Magra, AL; McDonald, CM; Patzek, SM; Shigenaga, JK | 1 |
| Jia, Y; Li, XH; Liu, Y; Zhang, HG | 1 |
| Deng, W; Jia, Y; Li, H; Li, X; Liao, Y; Liu, K; Tan, Z; Tian, G; Yuan, Z; Zhang, H; Zhang, Y | 1 |
| Chan, YY; Chang, KC; Chang, SH; Hung, MJ; Lai, EC; Lin, SJ; Shao, SC | 1 |
| Fan, Y; Zhang, K | 1 |
| Abdollahi, E; Delbandi, AA; Falak, R; Hajimiresmaiel, SJ; Keyhanfar, F; Shafiei, M | 1 |
| Wang, D; Wu, C; Yuan, L | 1 |
| Chen, D; Chen, P; He, B; Shen, Z; Yang, R; Yang, Y; Zhang, X | 1 |
| Balogh, DB; Barczi, A; Fekete, A; Fintha, A; Hodrea, J; Molnar, A; Saeed, A; Szabo, AJ; Wagner, LJ | 1 |
| Chen, K; Chu, W; Hou, J; Meng, N; Sun, C; Wang, Y; Xie, S; Yang, F | 1 |
| Feng, Y; Li, H; Li, J; Lin, K; Liu, X; Tian, J; Wang, X; Xi, X; Yin, L; Yu, B; Zhao, P | 1 |
| Choi, DH; Choi, IY; Chu, B; Ki, YJ; Kim, H; Lim, L; Song, H | 1 |
| Chen, S; Luo, J; Piao, C; Wang, L; Zhao, X | 1 |
| Iwamoto, M; Kadowaki, T; Kubota, N; Kubota, T; Sakurai, Y; Shioda, S; Wada, N; Yamauchi, T | 1 |
| Cao, Z; Dong, X; Fu, J; Tu, Q; Wu, F; Xie, H; Xu, H | 1 |
| Wang, D; Yuan, L; Zhou, Z | 1 |
| Gu, W; He, Y; Li, F; Yang, X; Yu, J; Zhang, T; Zhao, R | 1 |
| Anto-Michel, N; Bode, C; Füner, L; Gissler, MC; Goldberg, IJ; Härdtner, C; Hilgendorf, I; Hoppe, N; Mullick, A; Pennig, J; Scherrer, P; Stachon, P; Willecke, F; Wolf, D; Zirlik, A | 1 |
| Cai, C; Li, C; Sun, J; Ye, L; Zheng, X | 1 |
| Chen, L; Lei, X; Li, J; Li, WJ; Liu, X; Wang, K; Xing, SS; Yang, J; Yang, YT | 1 |
| Del Bo', C; Klimis-Zacas, D; Marino, M; Porrini, M; Riso, P; Tucci, M | 1 |
| Ahmad, P; Alvi, SS; Iqbal, D; Khan, MS | 1 |
| Li, X; Liu, L; Wang, S; Wu, M; Xing, Y; Yang, S; Zhao, R | 1 |
| Anker, SD; Elsasser, U; Fitchett, D; George, JT; Hantel, S; Inzucchi, SE; Jamal, W; Johansen, OE; Kaspers, S; Lund, SS; Mattheus, M; McGuire, DK; Pocock, S; von Eynatten, M; Wanner, C; Zinman, B | 1 |
| Ferreira, JP; Fitchett, D; George, J; Inzucchi, SE; Lauer, S; Ofstad, AP; Verma, S; Wanner, C; Zinman, B; Zwiener, I | 1 |
| Chen, X; Hu, Y; Jing, Y; Li, H; Liang, J; Shi, Y; Wu, J; Xiong, Q; Yan, Z; Yuan, J; Zhang, Q; Zhou, L | 1 |
| Aguilar-Ballester, M; Burks, DJ; González-Navarro, H; Herrero-Cervera, A; Martínez-Hervás, S; Real, JT; Taberner-Cortés, A; Vinué, Á | 1 |
| Ambery, P; Berwanger, O; Buenconsejo, J; Chopra, V; Esterline, R; Gasparyan, SB; Javaheri, A; Koch, GG; Kosiborod, M; Langkilde, AM; Martinez, F; Mukhtar, O; Oscarsson, J; Sjöström, CD; Verma, S | 1 |
| Cao, Y; Dong, P; Jia, L; Jiang, M; Li, C; Liang, Q; Shi, H; Song, T; Wang, P | 1 |
| Kang, L; Liu, Y; Wu, M; Xu, B; Xu, J | 1 |
| Guo, J; Jiao, J; Lu, D; Pu, Y; Sun, L; Tao, J; Xie, L; Yang, P | 1 |
| Chen, P; He, B; Hu, Q; Jin, H; Shen, Z; Tao, Y; Yang, R; Yang, Y; Zhang, L; Zhang, X | 1 |
| Han, SS; Hou, J; Li, CX; Liu, FY; Pang, WL; Sun, CB; Wang, C; Wen, J; Xing, HJ; Yan, JY; Yang, ZS; Yin, W; Ying, Y; Yuan, JL; Zhang, SQ; Zhou, LC | 1 |
| Han, X; Huang, Y; Long, X; Tang, J; Wang, X | 1 |
| Higashi, Y; Ikehara, Y; Inoue, T; Kawaguchi, A; Kimura, K; Machii, N; Maruhashi, T; Matsuzawa, Y; Node, K; Okada, Y; Oyama, JI; Sakuma, M; Sato, Y; Shima, KR; Shimabukuro, M; Sugiyama, S; Taguchi, I; Takamura, T; Tanaka, A; Teragawa, H; Tomiyama, H; Ueda, S; Yamaoka-Tojo, M; Yoshida, H | 1 |
| Jiao, Y; Li, H; Xie, M | 1 |
| Chen, X; Peng, Y; Tang, K; Xu, X | 1 |
| Dear, AE; Gaspari, T; Hu, Y; Liu, H; Simpson, RW; Spizzo, I; Widdop, RE | 1 |
| Chen, C; Chen, J; Chi, H; Dou, F; Liu, T; Sun, L; Sun, S; Xing, S | 1 |
| Li, W; Liu, F; Niu, X; Yao, Q; Zhao, J; Zhi, W | 1 |
| Dong, Z; Guo, P; Li, X; Liu, Q; Wang, S; Wu, C; Zhang, X; Zhou, Y | 1 |
| Al-Sharea, A; Goldberg, IJ; Hu, Y; Huggins, LA; Murphy, AJ; Nagareddy, PR | 1 |
| Eckel, RH; Koh, KK; Lim, S | 1 |
| Brunetti, L; Chiavaroli, A; Ferrante, C; Leone, S; Leporini, L; Menghini, L; Orlando, G; Recinella, L | 1 |
| Chen, YY; Jiang, MM; Liang, QQ; Lu, JX; Shi, H; Wen, SY; Wu, Q; Yao, ZH; Zhu, Y | 1 |
| Cheng, S; Huang, Z; Jia, Y; Tian, G; Zhang, Y; Zhao, D; Zhou, F | 1 |
| Cannon, CP; Fitchett, D; George, JT; Inzucchi, SE; Johansen, OE; Kaspers, S; McGuire, DK; Pfarr, E; Sambevski, S; Scirica, BM; Zinman, B | 1 |
| Hua, YQ; Peng, Y; Xu, J; Xu, XL; Zeng, Y | 1 |
| Chen, L; Peng, Y; Xu, J; Xu, XL; Zeng, Y | 1 |
| Li, J; Zhang, X; Zhu, Z | 1 |
| Agrogiannis, G; Dimitriadis, GK; Kaltsas, G; Kassi, E; Kostakis, ID; Nasiri-Ansari, N; Nikiteas, N; Papavassiliou, AG; Patel, VH; Randeva, HS; Randeva, MS | 1 |
| Li, F; Shen, Y; Wang, CH; Wang, YQ; Zhang, W | 2 |
| Liu, Y; Wang, X; Wang, Y; Xia, M; Zhang, Y | 2 |
| Chang, H; Chen, M; Jin, X; Ma, W; Mi, M; Peng, X; Wang, L; Yi, L; Zhang, T; Zhou, Y | 1 |
| Huang, C; Jing, X; Sun, Q; Wang, H; Yao, W; Zhang, W | 1 |
| Gu, C; Jing, X; Meng, G; Shao, H; Wang, H; Yao, W; Zhang, W | 1 |
| Cao, Y; Del Bo', C; Loft, S; Møller, P; Porrini, M; Riso, P; Roursgaard, M | 1 |
| Bai, XL; Bian, F; Chi, JY; Jin, S; Li, WJ; Li, YS; Wu, D; Wu, GJ; Xing, SS; Yang, XY; Zhang, CT; Zhang, YH; Zhang, YZ; Zheng, T | 1 |
| Hirano, T; Hiromura, M; Kohashi, K; Kushima, H; Mori, Y; Nagashima, M; Terasaki, M; Watanabe, T | 1 |
| Pantan, R; Suksamrarn, A; Tocharus, C; Tocharus, J | 1 |
| Cheng, CL; He, ZH; Li, M; Shi, CG; Wen, ZY; Yin, QL; Zhou, FH | 1 |
| Del Bo', C; Loft, S; Møller, P; Porrini, M; Riso, P; Roursgaard, M | 1 |
| Choi, SH; Han, JH; Jang, HC; Kim, KM; Kim, YB; Lee, DH; Lee, G; Lee, HS; Lim, S; Maeng, HJ; Oh, TJ; Park, KS | 1 |
| Chen, L; Deng, W; Lei, X; Leng, W; Liang, Z; Ouyang, X; Wu, M; Wu, Q | 1 |
| Kutoh, E; Murayama, T; Takizawa, Y; Wada, A | 1 |
| Wang, CH; Wang, YQ; Xu, XL; Zhang, W; Zhu, WZ | 1 |
| Cao, L; Gu, J; Han, C; He, C; Jin, Q; Wang, D; Wang, H; Wang, J; Wang, Y; Xu, B; Zhao, J | 1 |
| Benhabilès, N; Crombé, F; Geeraert, B; Geuns, JM; Holvoet, P; Hulsmans, M | 1 |
| Prasad, K | 2 |
| Li, F; Shen, Y; Wang, CH; Xu, XL; Zhang, W | 1 |
| Chen, CX; Li, J; Shen, YH | 1 |
| Gao, S; Jin, T; Li, D; Ling, W; Wang, D; Xia, M; Zhang, Y | 1 |
| Jin, T; Li, D; Ling, W; Wang, D; Wang, L; Xia, M; Xu, Y; Yan, X | 1 |
| Hazen, SL; Smith, JD | 1 |
| Chen, X; Fan, W; Huang, C; Yao, W; Zhang, W; Zhong, H | 1 |
| Almofti, MR; Chen, WS; Kang, H; Li, TJ; Lu, L; Rui, YC; Sun, LN; Yang, PY; Zhang, J | 1 |
| Lee, P; Prasad, K | 1 |
| Li, F; Wang, CH; Zhang, W; Zhu, WZ | 1 |
6 review(s) available for glucose, (beta-d)-isomer and Atherosclerosis
| Article | Year |
|---|---|
Pharmacological effects of polydatin in the treatment of metabolic diseases: A review.
Topics: AMP-Activated Protein Kinases; Atherosclerosis; Diabetes Mellitus; Glucosides; Gout; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Phosphatidylinositol 3-Kinases; Quality of Life; Stilbenes | 2022 |
Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.
Topics: Anticholesteremic Agents; Atherosclerosis; Cholesterol, LDL; Endothelial Cells; Fallopia japonica; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Plaque, Atherosclerotic; Receptors, LDL; Risk Factors; Stilbenes | 2020 |
Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Arteries; Atherosclerosis; Cardiovascular Agents; Glucosides; Humans; Inflammation Mediators; Lipid Metabolism; Oxidative Stress; Plaque, Atherosclerotic; Signal Transduction; Stilbenes | 2020 |
Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.
Topics: Albuminuria; Atherosclerosis; Benzhydryl Compounds; Body Weight; Canagliflozin; Cardiovascular Diseases; Cardiovascular System; Glucagon; Glucagon-Like Peptides; Glucosides; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Ketones; Lipids; Liraglutide; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Osmosis; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2018 |
Phytotherapic use of the Crocus sativus L. (Saffron) and its potential applications: A brief overview.
Topics: Alzheimer Disease; Animals; Atherosclerosis; Carotenoids; Crocus; Cyclohexenes; Depression; Glucosides; Humans; Neoplasms; Phytotherapy; Plant Extracts; Sexual Dysfunction, Physiological; Terpenes; Vitamin A | 2018 |
Natural products in regression and slowing of progression of atherosclerosis.
Topics: Animals; Antioxidants; Atherosclerosis; Biological Products; Butylene Glycols; Disease Progression; Flax; Glucosides; Humans; Hypercholesterolemia; Lignans; Oxidative Stress; Phytotherapy; Vitamin E | 2010 |
5 trial(s) available for glucose, (beta-d)-isomer and Atherosclerosis
| Article | Year |
|---|---|
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Equivalence Trials as Topic; Female; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; United States; Young Adult | 2020 |
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.
Topics: Aged; Atherosclerosis; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Diseases; Humans; Kidney Diseases; Male; Metabolic Syndrome; Middle Aged; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2020 |
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
Topics: Atherosclerosis; Benzhydryl Compounds; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cause of Death; Comorbidity; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Glucosides; Heart Failure; Humans; Hypertension; Kidney Diseases; Mortality; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Respiratory Insufficiency; SARS-CoV-2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2021 |
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelial Cells; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2017 |
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
Topics: Aged; Atherosclerosis; Benzhydryl Compounds; Cause of Death; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Male; Middle Aged; Patient Admission; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2019 |
71 other study(ies) available for glucose, (beta-d)-isomer and Atherosclerosis
| Article | Year |
|---|---|
Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Coculture Techniques; Cytoprotection; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ginsenosides; Human Umbilical Vein Endothelial Cells; Male; Monocytes; NF-E2-Related Factor 2; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Panax notoginseng; Phytotherapy; Plants, Medicinal; Rats, Wistar; Saponins; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Zymosan | 2016 |
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists.
Topics: Aminoquinolines; Animals; Atherosclerosis; Cholesterol Esters; Fatty Acid-Binding Proteins; Humans; Imiquimod; Lipopolysaccharides; Macrophage Activation; Macrophages; Membrane Proteins; Mice; Neoplasm Proteins; Perilipin-2; Poly I-C; Toll-Like Receptors; Triglycerides; Zymosan | 2010 |
Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Atherosclerosis; C-Reactive Protein; Chemokine CCL2; Cholesterol, Dietary; Diet, Atherogenic; Disease Models, Animal; Interleukin-6; Lipids; Male; Medicine, Chinese Traditional; NF-kappa B; Panax notoginseng; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Zymosan | 2010 |
Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Topics: Animals; Aorta; Atherosclerosis; Biological Transport; Disease Models, Animal; Foam Cells; Focal Adhesion Kinase 1; Integrins; Male; NF-kappa B; Panax notoginseng; Phosphorylation; Phytotherapy; Plant Extracts; Plaque, Atherosclerotic; Rats; Rats, Wistar; Saponins; Threonine; Zymosan | 2011 |
Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease.
Topics: Aged; Atherosclerosis; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Taiwan; Time Factors; Treatment Outcome | 2021 |
Verbascoside inhibits the progression of atherosclerosis in high fat diet induced atherosclerosis rat model.
Topics: Animals; Atherosclerosis; Diet, High-Fat; Glucosides; Phenols; Rats | 2021 |
Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Benzhydryl Compounds; Gene Expression Regulation; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; Inflammation Mediators; Macrophage Activation; Macrophages; NF-kappa B; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Toll-Like Receptor 4 | 2022 |
Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1.
Topics: Atherosclerosis; Cell Proliferation; Cell Survival; Cells, Cultured; Coronary Disease; Cytoprotection; Flavanones; Gene Expression Regulation; Glucosides; Humans; Lipoproteins, LDL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protective Agents; Sirtuin 1; Up-Regulation | 2022 |
Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro.
Topics: Animals; Atherosclerosis; Glucosides; Hydrolyzable Tannins; Myeloid Differentiation Factor 88; NF-kappa B; Rabbits; Scavenger Receptors, Class E; Signal Transduction | 2022 |
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Heart Failure; Male; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Dihydrohomoplantagin and Homoplantaginin, Major Flavonoid Glycosides from
Topics: Animals; Atherosclerosis; Endothelial Cells; Endothelium; Flavonoids; Glucosides; Glycosides; Lipoproteins, LDL; Mice; NF-E2-Related Factor 2; Salvia; Signal Transduction | 2022 |
Anti-atherosclerotic effects of geraniin through the gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway in mice.
Topics: Animals; Atherosclerosis; Gastrointestinal Microbiome; Glucosides; Hydrolyzable Tannins; Methylamines; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S | 2022 |
Plantamajoside Attenuates Neointima Formation via Upregulation of Tissue Inhibitor of Metalloproteinases in Balloon-Injured Rats.
Topics: Animals; Atherosclerosis; Catechols; Cell Movement; Cell Proliferation; Cells, Cultured; Glucosides; Hyperplasia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinases; Up-Regulation | 2022 |
The sodium-glucose co-transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE-deficient mice with streptozotocin-induced diabetes.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Insulin; Interleukin-6; Mice; Mice, Knockout, ApoE; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2022 |
Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Glucosides; Inflammation; Lipoproteins, LDL; Macrophages; Mice; NF-kappa B; Plaque, Atherosclerotic; RNA; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Polydatin reverses oxidation low lipoprotein (oxLDL)-induced apoptosis of human umbilical vein endothelial cells via regulating the miR-26a-5p/BID axis.
Topics: Apoptosis; Atherosclerosis; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; MicroRNAs; Stilbenes | 2022 |
Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE
Topics: Administration, Oral; Animals; Aorta; Atherosclerosis; Chemokine CCL2; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Glucosides; Humans; Inflammation; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Mice; Mice, Knockout, ApoE; Polygonum; Stilbenes; Triglycerides; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2020 |
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Male; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Orientin suppresses oxidized low-density lipoproteins induced inflammation and oxidative stress of macrophages in atherosclerosis.
Topics: Animals; Atherosclerosis; CD36 Antigens; Cytokines; Flavonoids; Glucosides; Inflammation; Lipid Droplets; Lipoproteins, LDL; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; RAW 264.7 Cells | 2020 |
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.
Topics: Animals; Atherosclerosis; Dose-Response Relationship, Drug; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Knockout; Phenols; Plaque, Atherosclerotic; Pyroptosis; Rhodiola | 2020 |
Modulation of Adhesion Process, E-Selectin and VEGF Production by Anthocyanins and Their Metabolites in an
Topics: Anthocyanins; Atherosclerosis; Cell Adhesion; Cell Death; Cell Survival; E-Selectin; Gallic Acid; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Metabolome; Models, Biological; Solubility; THP-1 Cells; Vanillic Acid; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2020 |
Polydatin alleviates high-fat diet induced atherosclerosis in apolipoprotein E-deficient mice by autophagic restoration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Autophagy; Diet, High-Fat; Glucosides; Male; Mice, Knockout, ApoE; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plaque, Atherosclerotic; Proto-Oncogene Proteins c-akt; Stilbenes; TOR Serine-Threonine Kinases | 2021 |
Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Computational Biology; Disease Models, Animal; Fasting; Glucose; Glucosides; Immunohistochemistry; Insulin Resistance; Macrophages; Mice; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice.
Topics: 3-Hydroxybutyric Acid; Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Glucose; Glucosides; Glycogen; Hypercholesterolemia; Lipidomics; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Phenols; Proton Magnetic Resonance Spectroscopy | 2021 |
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Body Weight; Disease Progression; Glucosides; Inflammation; Lipids; Male; Mice; Neuropeptide Y; Norepinephrine; Renin-Angiotensin System; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System | 2021 |
Gastrodin induces lysosomal biogenesis and autophagy to prevent the formation of foam cells via AMPK-FoxO1-TFEB signalling axis.
Topics: AMP-Activated Protein Kinases; Animals; Atherosclerosis; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Benzyl Alcohols; Foam Cells; Forkhead Box Protein O1; Gene Expression Regulation; Glucosides; Lysosomes; Macrophages; Mice | 2021 |
Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.
Topics: Animals; Atherosclerosis; Carotid Artery, Common; Diet, High-Fat; Disease Models, Animal; Glucosides; Humans; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; RAW 264.7 Cells; Swine; Swine, Miniature | 2021 |
Gastrodia remodels intestinal microflora to suppress inflammation in mice with early atherosclerosis.
Topics: Acetic Acid; Animals; Aorta; Atherosclerosis; Benzyl Alcohols; Butyric Acid; Disease Models, Animal; Drugs, Chinese Herbal; Fatty Acids, Volatile; Gastrodia; Gastrointestinal Microbiome; Glucosides; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Intestinal Mucosa; Lipids; Mice, Inbred C57BL; Propionates; Tight Junction Proteins; Tumor Necrosis Factor-alpha | 2021 |
Salidroside inhibits endothelial‑mesenchymal transition via the KLF4/eNOS signaling pathway.
Topics: Atherosclerosis; Cell Line; Cell Movement; Down-Regulation; Endothelial Cells; Glucosides; Humans; Kruppel-Like Factor 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phenols; RNA, Small Interfering; Signal Transduction | 2021 |
Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation.
Topics: Animals; Atherosclerosis; Diet, High-Fat; Glucosides; Inflammation; Monoterpenes; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Toll-Like Receptor 4 | 2017 |
2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Biological Transport; Cholesterol; Fatty Liver; Foam Cells; Glucosides; Hyperlipidemias; Inflammation; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; RAW 264.7 Cells; Stilbenes | 2018 |
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Topics: Animals; Aorta, Abdominal; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Plasminogen Activator Inhibitor 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vasodilation | 2018 |
Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model.
Topics: Animals; Atherosclerosis; Biomarkers; Cell Cycle; Cell Cycle Proteins; Cell Line; Cellular Senescence; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Genes, p53; Glucosides; Humans; Phenols | 2018 |
Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO-1 through MAPKs and NF-κB pathway.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glucosides; Heme Oxygenase-1; Humans; Interleukin-6; Macrophages; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Monoterpenes; Muscle, Smooth, Vascular; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Phenylpropanoid glucosides from Tadehagi triquetrum inhibit oxLDL-evoked foam cell formation through modulating cholesterol homeostasis in RAW264.7 macrophages.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Biological Transport; CD36 Antigens; Cell Line; Cholesterol; Down-Regulation; Fabaceae; Foam Cells; Glucosides; Homeostasis; Lipid Metabolism; Lipoproteins, LDL; Mice; Molecular Structure; Phytochemicals; RAW 264.7 Cells; Receptors, Scavenger | 2019 |
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cholesterol, Dietary; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Heparin; Hyperlipidemias; Lipoproteins; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Phlorhizin; Proteoglycans; Receptors, LDL; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2018 |
Modulation of hepatic lipidome by rhodioloside in high-fat diet fed apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Chromatography, Liquid; Diet, High-Fat; Dyslipidemias; Glucosides; Lipid Metabolism; Lipids; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Phenols; Tandem Mass Spectrometry | 2020 |
Polydatin Attenuates Atherosclerosis in ApoE
Topics: Animals; Atherosclerosis; Cholesterol; Cytokines; Down-Regulation; Drugs, Chinese Herbal; Glucosides; Macrophages; Mice; Mice, Knockout; Nicotinamide Phosphoribosyltransferase; Phytotherapy; RAW 264.7 Cells; RNA, Small Interfering; Stilbenes | 2018 |
2, 3, 4', 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms.
Topics: Aging; Animals; Aorta; Atherosclerosis; Diet, High-Fat; Glucosides; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Receptors, LDL; Stilbenes | 2019 |
Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Biological Transport; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet, High-Fat; Fatty Liver; Foam Cells; Glucosides; Lipid Metabolism; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Stilbenes | 2019 |
Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway.
Topics: Atherosclerosis; Autophagy; Drug Evaluation, Preclinical; Endothelial Cells; Forkhead Box Protein O1; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Oxidative Stress; Phenols; Phytotherapy; Plant Extracts; Rhodiola; Sirtuin 1 | 2019 |
Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice.
Topics: Administration, Oral; Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diastole; Diet, High-Fat; Fasting; Glucosides; Heart Rate; Hemodynamics; Lipids; Metalloproteases; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; RNA, Messenger | 2019 |
2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside suppresses expression of adhesion molecules in aortic wall of dietary atherosclerotic rats and promonocytic U937 cells.
Topics: Animals; Aorta; Atherosclerosis; Cell Adhesion Molecules; Diet, High-Fat; Gene Expression Regulation; Glucosides; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Monocyte-Macrophage Precursor Cells; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Stilbenes; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2013 |
Supplementation of cyanidin-3-O-β-glucoside promotes endothelial repair and prevents enhanced atherogenesis in diabetic apolipoprotein E-deficient mice.
Topics: Acetylcholine; AMP-Activated Protein Kinases; Animals; Anthocyanins; Aorta; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet; Dietary Supplements; Endothelial Cells; Endothelium; Glucosides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Stem Cells; Streptozocin; Wound Healing | 2013 |
Delphinidin-3-glucoside protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury by autophagy upregulation via the AMPK/SIRT1 signaling pathway.
Topics: AMP-Activated Protein Kinases; Anthocyanins; Antioxidants; Apoptosis; Atherosclerosis; Autophagy; Cell Survival; Cells, Cultured; Dietary Supplements; Endothelium, Vascular; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Microscopy, Electron, Transmission; Phosphorylation; Protein Processing, Post-Translational; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirtuin 1 | 2014 |
Tetrahydroxystilbene glucoside protects against oxidized LDL-induced endothelial dysfunction via regulating vimentin cytoskeleton and its colocalization with ICAM-1 and VCAM-1.
Topics: Apoptosis; Atherosclerosis; Caspase 3; Cells, Cultured; Cytoskeleton; Down-Regulation; Endothelial Cells; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; NF-kappa B; Protective Agents; Signal Transduction; Smad Proteins, Receptor-Regulated; Stilbenes; Vascular Cell Adhesion Molecule-1; Vimentin | 2014 |
Tetrahydroxystilbene glucoside improves TNF-α-induced endothelial dysfunction: involvement of TGFβ/Smad pathway and inhibition of vimentin expression.
Topics: Active Transport, Cell Nucleus; Apoptosis; Atherosclerosis; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Gene Expression Regulation, Developmental; Glucosides; Humans; L-Lactate Dehydrogenase; Polygonum; Signal Transduction; Smad Proteins; Stilbenes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Umbilical Veins; Vimentin | 2015 |
Anthocyanins and phenolic acids from a wild blueberry (Vaccinium angustifolium) powder counteract lipid accumulation in THP-1-derived macrophages.
Topics: Anthocyanins; Antioxidants; Atherosclerosis; Blueberry Plants; Carotenoids; Cell Line, Tumor; Cell Survival; Dietary Fiber; Dietary Sucrose; Fatty Acids; Gallic Acid; Glucosides; Humans; Hydroxybenzoates; Lipid Metabolism; Macrophages; Plant Extracts; Powders; Protective Agents; Trace Elements; Vitamins | 2016 |
Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Diet, High-Fat; Endothelial Cells; Glucosides; Male; Mice; Mitochondria; Nitric Oxide; Nitric Oxide Synthase Type III; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction | 2015 |
Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Foam Cells; Gene Expression; Glucose Tolerance Test; Glucosides; Hyperglycemia; Hypoglycemic Agents; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells.
Topics: Angiotensin II; Anthocyanins; Anti-Inflammatory Agents; Atherosclerosis; Atorvastatin; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Induction; Glucosides; Humans; Intercellular Adhesion Molecule-1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Vascular Cell Adhesion Molecule-1; Vasculitis | 2016 |
[Effect of polydatin on miR-214 expression and liver function in ApoE-/- mice].
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Lipids; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Stilbenes; Superoxide Dismutase | 2016 |
Different effects of anthocyanins and phenolic acids from wild blueberry (Vaccinium angustifolium) on monocytes adhesion to endothelial cells in a TNF-α stimulated proinflammatory environment.
Topics: Anthocyanins; Atherosclerosis; Blueberry Plants; Cell Adhesion; E-Selectin; Endothelium, Vascular; Gallic Acid; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hydroxybenzoates; Intercellular Adhesion Molecule-1; Monocytes; NF-kappa B; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE
Topics: Adipose Tissue; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blotting, Western; CD11c Antigen; Cell Line; Cell Proliferation; Diabetes Mellitus, Type 2; Diet, Western; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Insulin Resistance; Liver; Male; Mice; Rats; Real-Time Polymerase Chain Reaction; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Bone Marrow; Diabetes Complications; Diabetes Mellitus, Experimental; Glucose; Glucosides; Inflammasomes; Interleukin-18; Interleukin-1beta; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy.
Topics: Atherosclerosis; Blood Glucose; Body Mass Index; Canagliflozin; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Thiophenes; Triglycerides | 2017 |
[Effects of 2, 3, 4', 5-tetrahydroxystilbene -2-O-beta-D glucoside on content of nitric oxide synthase and expression of nitric oxide synthase in artery vessels of experimental atherosclerotic rats].
Topics: Animals; Arteries; Atherosclerosis; Gene Expression Regulation, Enzymologic; Glucosides; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2008 |
Effects of 2,3,4',5-tetrahydroxystilbene 2-O-beta-D-glucoside on vascular endothelial dysfunction in atherogenic-diet rats.
Topics: Animals; Aorta; Atherosclerosis; Disease Models, Animal; Drugs, Chinese Herbal; Endothelium, Vascular; Glucosides; Male; Microscopy, Electron, Transmission; Nitrates; Nitric Oxide Synthase; Nitrites; Polygonum; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stilbenes | 2009 |
Application of poly(dimethylsiloxane)/glass microchip for fast electrophoretic separation of serum small, dense low-density lipoprotein.
Topics: Aged; Atherosclerosis; Blood Protein Electrophoresis; Cellulose; Detergents; Dimethylpolysiloxanes; Electrophoresis, Capillary; Glass; Glucosides; Humans; Lipoproteins; Lipoproteins, LDL; Male; Microchip Analytical Procedures; Reproducibility of Results | 2009 |
Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice.
Topics: Adiponectin; Animals; Antioxidants; Atherosclerosis; Blood Glucose; Body Weight; Diterpenes, Kaurane; Glucosides; Insulin; Insulin Resistance; Mice; Mice, Obese; Obesity; Oxidative Stress; Signal Transduction; Sweetening Agents; Triglycerides | 2010 |
[The expression of matrix metalloproteinase-2,9 on atherosclerosis in experimental rats by treatment of 2,3,4',5-tetrahydroxystilbene -2-0-beta-D glucoside].
Topics: Animals; Atherosclerosis; C-Reactive Protein; Glucosides; Interferon-alpha; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Polygonum; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stilbenes | 2009 |
Effects of total glucosides from paeony (Paeonia lactiflora Pall) roots on experimental atherosclerosis in rats.
Topics: Animals; Atherosclerosis; Cytokines; Enzyme-Linked Immunosorbent Assay; Glucosides; Lipids; Male; Paeonia; Plant Roots; Rats; Rats, Sprague-Dawley | 2011 |
Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice.
Topics: Animals; Anthocyanins; Apolipoproteins E; Atherosclerosis; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Gene Knockdown Techniques; Glucosides; Hepatocytes; Hypercholesterolemia; Liver; Liver X Receptors; Male; Mice; Orphan Nuclear Receptors; Up-Regulation | 2012 |
Supplementation with cyanidin-3-O-β-glucoside protects against hypercholesterolemia-mediated endothelial dysfunction and attenuates atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Anthocyanins; Aorta; Apolipoproteins E; Atherosclerosis; Dietary Fats; Dietary Supplements; Endothelium, Vascular; Glucosides; Hypercholesterolemia; Hypolipidemic Agents; Male; Mice; Mice, Knockout; Nitric Oxide; Oxidative Stress | 2012 |
Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b.
Topics: Animals; Anthocyanins; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Cells, Cultured; Cholesterol; Glucosides; HEK293 Cells; Humans; Hydroxybenzoates; Intestinal Absorption; Intestines; Lipoproteins; Macrophages, Peritoneal; Metagenome; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; MicroRNAs | 2012 |
An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport.
Topics: Animals; Anthocyanins; Atherosclerosis; Cholesterol; Glucosides; Humans; Metagenome; MicroRNAs | 2012 |
Proteomic analysis for anti-atherosclerotic effect of tetrahydroxystilbene glucoside in rats.
Topics: Animals; Annexin A1; Aorta; Apolipoprotein A-I; Apoptosis; Atherosclerosis; Calreticulin; Cell Adhesion; Cholesterol; Down-Regulation; Gene Expression Regulation; Glucosides; HSP70 Heat-Shock Proteins; Inflammation; Male; Proteome; Proteomics; Rats; Rats, Sprague-Dawley; Stilbenes; Up-Regulation; Vimentin | 2013 |
Reduction of atherosclerosis in cholesterol-fed rabbits and decrease of expressions of intracellular adhesion molecule-1 and vascular endothelial growth factor in foam cells by a water-soluble fraction of Polygonum multiflorum.
Topics: Animals; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Foam Cells; Glucosides; Humans; Intercellular Adhesion Molecule-1; Male; Medicine, Chinese Traditional; Polygonum; Rabbits; Stilbenes; Triglycerides; U937 Cells; Vascular Endothelial Growth Factor A | 2005 |
Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; Body Weight; Butylene Glycols; Cholesterol, Dietary; Female; Glucosides; Hypercholesterolemia; Lipids; Luminescence; Malondialdehyde; Pentoxifylline; Rabbits | 2007 |
Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
Topics: Animals; Aorta; Atherosclerosis; Butylene Glycols; Flax; Glucosides; Hypercholesterolemia; Lipids; Luminescence; Malondialdehyde; Oxidative Stress; Plant Preparations; Rabbits | 2008 |
2,3,4',5-Tetrahydroxystilbene-2-O-beta-D-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glucosides; Inflammation; Male; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; Simvastatin; Stilbenes | 2008 |